As of January 22, 2025, MediciNova (MNOV) has a market cap of $88.774 million USD. According to our data, MediciNova is ranked No.7776 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $88.77 M |
-13.81%
|
Dec 31, 2024 | $0.10 B |
40.00%
|
Dec 29, 2023 | $73.57 M |
-26.83%
|
Dec 30, 2022 | $0.10 B |
-23.51%
|
Dec 31, 2021 | $0.13 B |
-49.05%
|
Dec 31, 2020 | $0.26 B |
-21.96%
|
Dec 31, 2019 | $0.33 B |
-17.50%
|
Dec 31, 2018 | $0.40 B |
26.28%
|
Dec 29, 2017 | $0.32 B |
7.30%
|
Dec 30, 2016 | $0.30 B |
69.86%
|
Dec 31, 2015 | $0.17 B |
16.78%
|
Dec 31, 2014 | $0.15 B |
42.06%
|
Dec 31, 2013 | $0.10 B |
30.49%
|
Dec 31, 2012 | $80.44 M |
-3.53%
|
Dec 30, 2011 | $83.38 M |
-63.91%
|
Dec 31, 2010 | $0.23 B |
-33.10%
|
Dec 31, 2009 | $0.35 B |
342.77%
|
Dec 31, 2008 | $77.98 M |
-65.43%
|
Dec 31, 2007 | $0.23 B |
-65.36%
|
Dec 29, 2006 | $0.65 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
bluebird bio
BLUE
|
$76.22 M |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Market Cap | = | MNOV Stock Price | * | MNOV Shares Outstanding |
= | $1.81 | * | 49.05 M | |
= | $88.77 M |